Metabolism Medication Toxicity: Clinical Trials

5 trials for Metabolism Medication Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Metabolism Medication Toxicity: new trials by email Literature Review of Metabolism Medication Toxicity trials Research Report on Metabolism Medication Toxicity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methadone Dose Monitoring With a Remote Medication Monitor
Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo, Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo, ISF Extraction Device 2 - Methadone Toxicity, Methadone Overdose
Not yet recruitingCari Health Inc.302025-04-262025-02-20
Assessment of Methadone Dose Taken
Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivo, Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo, ISF Extraction Device 2 - Methadone Toxicity, Methadone Overdose
RecruitingCari Health Inc.302024-08-262025-02-13
Pharmacology Space Kit (PSK) - Dried Blood Spot for Caffeine Pharmacokinetics Under Microgravity Conditions
prick test - Drug Mechanism, Metabolism Medication Toxicity
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France302023-03-272025-09-02
The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
Tacrolimus, Unbound tacrolimus measurement, CYP3A4 and CYP3A5 genotyping - Immunosuppression, Kidney Transplant Rejection
UnknownNational Science Centre, Poland3802020-08-012022-04-22
Pharmacogenomic Profiling of Pediatric Patients
Mental Disorders, Metabolism Medication Toxicity
CompletedUniversity of Alabama at Birmingham1002016-06-012018-02-20

Narrower conditions

Chronic Pain (2)  ·  Drug Metabolism, Poor, CYP2D6-Related (2)  ·  Drug Overdose (1)  ·  Genetic Predisposition to Disease (1)  ·  Mental Disorders (1)  ·  Space Motion Sickness (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (3)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Chemically-Induced Disorders (1)  ·  Disease Attributes (1)  ·  Disease Susceptibility (1)  ·  Drug Misuse (1)  ·  Motion Sickness (1)  ·  Pathologic Processes (1)  ·  Prescription Drug Misuse (1)  ·  Substance-Related Disorders (1)

Interventions

Methadone (2)  ·  Patch Tests (1)  ·  Tacrolimus (1)

Sponsors

Cari Health Inc. (2)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  National Science Centre, Poland (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (3)  ·  France (1)  ·  Poland (1)

Top investigators

Charmaine Semenluk, MD (2)  ·  Pallavi Ghosh, MD (1)

Results publications

PMID 39473131